Rise in Targeted Therapies Drives Need for Small-Volume Manufacturing
Rise in Targeted Therapies Drives Need for Small-Volume Manufacturing
バイオ医薬品市場は過去15年間、着実に2桁成長を続け、今やFDAが承認する新規化合物（NME）の4分の1強を占めています。

Added Date:

2022-05-15

Filters:

Filter Category Filter Values
Specialty
  • Commercial manufacturing
Month
  • August
Year
  • 2020
Capability
  • Steriles
Asset Type
  • Whitepaper
Region
  • Global
Market Category
  • Large molecule

Country Availability:


()

Gated Form:

None Set